help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dakin, C. L.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dakin, C. L.
Right arrow Articles by Bloom, S. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Endocrinology Vol. 142, No. 10 4244-4250
Copyright © 2001 by The Endocrine Society

ARTICLES

Oxyntomodulin Inhibits Food Intake in the Rat

C. L. Dakin, I. Gunn, C. J. Small, C. M. B. Edwards, D. L. Hay, D. M. Smith1, M. A. Ghatei and S. R. Bloom

Endocrine Unit, Department of Metabolic Medicine, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom W12 0NN

Address all correspondence and requests for reprints to: Prof. S. R. Bloom, Department of Metabolic Medicine, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom W12 0NN. E-mail: s.bloom{at}ic.ac.uk

Oxyntomodulin is derived from proglucagon processing in the intestine and the central nervous system. To date, no role in the central nervous system has been demonstrated. We report here that oxyntomodulin inhibits refeeding when injected intracerebroventricularly and into the hypothalamic paraventricular nucleus of 24-h fasted rats [intracerebroventricularly and into the paraventricular nucleus, 1 h, oxyntomodulin (1 nmol), 3.1 ± 0.5 g; saline, 6.2 ± 0.4 g; P < 0.005]. In addition, oxyntomodulin inhibits food intake in nonfasted rats injected at the onset of the dark phase (intracerebroventricularly, 1 h: oxyntomodulin, 3 nmol, 1.1 ± 0.19 g vs. saline, 2.3 ± 0.2 g; P < 0.05). This effect of oxyntomodulin on feeding is of a similar time course and magnitude as that of an equimolar dose of glucagon-like peptide-1. Other proglucagon-derived products investigated [glucagon, glicentin (intracerebroventricularly, 3 nmol; into the paraventricular nucleus, 1 nmol), and spacer peptide-1 (intracerebroventricularly and into the paraventricular nucleus, 3 nmol)] had no effect on feeding at any time point examined. The anorectic effect of oxyntomodulin (intracerebroventricularly, 3 nmol; into the paraventricular nucleus, 1 nmol) was blocked when it was coadministered with the glucagon-like peptide-1 receptor antagonist, exendin-(9–39) (intracerebroventricularly, 100 nmol; into the paraventricular nucleus, 10 nmol). However, oxyntomodulin has a lower affinity for the glucagon-like peptide-1 receptor compared with glucagon-like peptide-1 (IC50: oxyntomodulin, 8.2 nM; glucagon-like peptide-1, 0.16 nM). One explanation for this is that there might be an oxyntomodulin receptor to which exendin-(9–39) can also bind and act as an antagonist.




This article has been cited by other articles:


Home page
 DiabetesHome page
A. Pocai, P. E. Carrington, J. R. Adams, M. Wright, G. Eiermann, L. Zhu, X. Du, A. Petrov, M. E. Lassman, G. Jiang, et al.
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Diabetes, October 1, 2009; 58(10): 2258 - 2266.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Patterson, K. G. Murphy, S. R. Patel, N. A. Patel, H. C. Greenwood, J. H. Cooke, D. Campbell, G. A. Bewick, M. A. Ghatei, and S. R. Bloom
Hypothalamic Injection of Oxyntomodulin Suppresses Circulating Ghrelin-Like Immunoreactivity
Endocrinology, August 1, 2009; 150(8): 3513 - 3520.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. R. Druce, J. S. Minnion, B. C. T. Field, S. R. Patel, J. C. Shillito, M. Tilby, K. E. L. Beale, K. G. Murphy, M. A. Ghatei, and S. R. Bloom
Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs
Endocrinology, April 1, 2009; 150(4): 1712 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Maida, J. A. Lovshin, L. L. Baggio, and D. J. Drucker
The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances {beta}-Cell Function but Does Not Inhibit Gastric Emptying in Mice
Endocrinology, November 1, 2008; 149(11): 5670 - 5678.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. C. Woods and D. A. D'Alessio
Central Control of Body Weight and Appetite
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s37 - s50.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle
The Obesity Epidemic: Pharmacological Challenges
Mol. Interv., April 1, 2008; 8(2): 82 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
O. B. Chaudhri, K. Wynne, and S. R. Bloom
Can Gut Hormones Control Appetite and Prevent Obesity?
Diabetes Care, February 1, 2008; 31(Supplement_2): S284 - S289.
[Abstract] [Full Text] [PDF]

Home page
 Poult. Sci.Home page
J. D. Latshaw
Daily Energy Intake of Broiler Chickens is Altered by Proximate Nutrient Content and Form of the Diet
Poult. Sci., January 1, 2008; 87(1): 89 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. T. Parlevliet, A. C. Heijboer, J. P. Schroder-van der Elst, L. M. Havekes, J. A. Romijn, H. Pijl, and E. P. M. Corssmit
Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E142 - E147.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling
Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha}
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 148 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. L. Sowden, D. J. Drucker, D. Weinshenker, and S. J. Swoap
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R962 - R970.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. G. Murphy, W. S. Dhillo, and S. R. Bloom
Gut Peptides in the Regulation of Food Intake and Energy Homeostasis
Endocr. Rev., December 1, 2006; 27(7): 719 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
O. Chaudhri, C. Small, and S. Bloom
Gastrointestinal hormones regulating appetite
Phil Trans R Soc B, July 29, 2006; 361(1471): 1187 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Druce and S R Bloom
The regulation of appetite
Arch. Dis. Child., February 1, 2006; 91(2): 183 - 187.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
E. M Sinclair and D. J. Drucker
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
Physiology, October 1, 2005; 20(5): 357 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev, October 1, 2005; 85(4): 1131 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. K. Badman and J. S. Flier
The Gut and Energy Balance: Visceral Allies in the Obesity Wars
Science, March 25, 2005; 307(5717): 1909 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
K. Wynne, S. Stanley, B. McGowan, and S. Bloom
Appetite control
J. Endocrinol., February 1, 2005; 184(2): 291 - 318.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. L. Dakin, C. J. Small, R. L. Batterham, N. M. Neary, M. A. Cohen, M. Patterson, M. A. Ghatei, and S. R. Bloom
Peripheral Oxyntomodulin Reduces Food Intake and Body Weight Gain in Rats
Endocrinology, June 1, 2004; 145(6): 2687 - 2695.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. R. Druce, C. J. Small, and S. R. Bloom
Minireview: Gut Peptides Regulating Satiety
Endocrinology, June 1, 2004; 145(6): 2660 - 2665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Stanley, K. Wynne, and S. Bloom
Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G693 - G697.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Cohen, S. M. Ellis, C. W. Le Roux, R. L. Batterham, A. Park, M. Patterson, G. S. Frost, M. A. Ghatei, and S. R. Bloom
Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4696 - 4701.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Vrang, C. B. Phifer, M. M. Corkern, and H.-R. Berthoud
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R470 - R478.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhu, C. Tamvakopoulos, D. Xie, J. Dragovic, X. Shen, J. E. Fenyk-Melody, K. Schmidt, A. Bagchi, P. R. Griffin, N. A. Thornberry, et al.
The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides: IN VIVO METABOLISM OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE-(1-38)
J. Biol. Chem., June 13, 2003; 278(25): 22418 - 22423.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. L. Dakin, C. J. Small, A. J. Park, A. Seth, M. A. Ghatei, and S. R. Bloom
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1173 - E1177.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society